118 related articles for article (PubMed ID: 18210825)
1. [International project--MGTX study].
Yoshikawa H
Rinsho Shinkeigaku; 2007 Nov; 47(11):880-2. PubMed ID: 18210825
[TBL] [Abstract][Full Text] [Related]
2. Status of the thymectomy trial for nonthymomatous myasthenia gravis patients receiving prednisone.
Newsom-Davis J; Cutter G; Wolfe GI; Kaminski HJ; Jaretzki A; Minisman G; Aban I; Conwit R
Ann N Y Acad Sci; 2008; 1132():344-7. PubMed ID: 18567886
[TBL] [Abstract][Full Text] [Related]
3. [Current status and future prospects of therapy for myasthenia gravis: considering thymectomy].
Yoshikawa H; Iwasa K; Takamori M
Brain Nerve; 2011 Jul; 63(7):729-36. PubMed ID: 21747143
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BRF; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Verschuuren JJGM; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Silvestri NJ; Conwit R; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
Lancet Neurol; 2019 Mar; 18(3):259-268. PubMed ID: 30692052
[TBL] [Abstract][Full Text] [Related]
5. [The Significance of Extended Thymectomy in Non-Thymomatous Myasthenia Gravis: an MGTX Study].
Yoshikawa H
Brain Nerve; 2017 Jan; 69(1):51-59. PubMed ID: 28126978
[TBL] [Abstract][Full Text] [Related]
6. Randomized Trial of Thymectomy in Myasthenia Gravis.
Wolfe GI; Kaminski HJ; Aban IB; Minisman G; Kuo HC; Marx A; Ströbel P; Mazia C; Oger J; Cea JG; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BR; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Garcia Ramos GS; Verschuuren JJ; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Odenkirchen J; Sonett JR; Jaretzki A; Newsom-Davis J; Cutter GR;
N Engl J Med; 2016 Aug; 375(6):511-22. PubMed ID: 27509100
[TBL] [Abstract][Full Text] [Related]
7. Experience with starting tacrolimus postoperatively after transsternal extended thymectomy in patients with myasthenia gravis.
Ponseti JM; Azem J; Fort JM; López-Cano M; Vilallonga R; Gamez J; Armengol M
Curr Med Res Opin; 2006 May; 22(5):885-95. PubMed ID: 16709310
[TBL] [Abstract][Full Text] [Related]
8. Post-thymectomy combined treatment of prednisone and tacrolimus versus prednisone alone for consolidation of complete stable remission in patients with myasthenia gravis: a non-randomized, non-controlled study.
Ponseti JM; Gamez J; Azem J; Fort JM; López-Cano M; Vilallonga R; Buera M; Armengol M
Curr Med Res Opin; 2007 Jun; 23(6):1269-78. PubMed ID: 17559724
[TBL] [Abstract][Full Text] [Related]
9. Minimal manifestation status and prednisone withdrawal in the MGTX trial.
Lee I; Kuo HC; Aban IB; Cutter GR; McPherson T; Kaminski HJ; Sussman J; Ströbel P; Oger J; Cea G; Heckmann JM; Evoli A; Nix W; Ciafaloni E; Antonini G; Witoonpanich R; King JO; Beydoun SR; Chalk CH; Barboi AC; Amato AA; Shaibani AI; Katirji B; Lecky BRF; Buckley C; Vincent A; Dias-Tosta E; Yoshikawa H; Waddington-Cruz M; Pulley MT; Rivner MH; Kostera-Pruszczyk A; Pascuzzi RM; Jackson CE; Verschuuren JJG; Massey JM; Kissel JT; Werneck LC; Benatar M; Barohn RJ; Tandan R; Mozaffar T; Conwit R; Minisman G; Sonett JR; Wolfe GI;
Neurology; 2020 Aug; 95(6):e755-e766. PubMed ID: 32611638
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcome after extended thymectomy combined postoperative high-dose steroid therapy for juvenile myasthenia gravis.
Kanzaki M; Obara T; Sasano S; Hikawa Y; Onuki T
Ann Thorac Cardiovasc Surg; 2008 Apr; 14(2):119-22. PubMed ID: 18414352
[TBL] [Abstract][Full Text] [Related]
11. Does perioperative high-dose prednisolone have clinical benefits for generalized myasthenia gravis?
Sekine Y; Kawaguchi N; Hamada C; Sekiguchi H; Yasufuku K; Iyoda A; Shibuya K; Fujisawa T
Eur J Cardiothorac Surg; 2006 Jun; 29(6):908-13. PubMed ID: 16675232
[TBL] [Abstract][Full Text] [Related]
12. Influence of ectopic thymic tissue on clinical outcome following extended thymectomy in generalized seropositive nonthymomatous myasthenia gravis.
Ponseti JM; Gamez J; Vilallonga R; Ruiz C; Azem J; López-Cano M; Armengol M
Eur J Cardiothorac Surg; 2008 Nov; 34(5):1062-7. PubMed ID: 18760934
[TBL] [Abstract][Full Text] [Related]
13. Correlation of Quantitative Myasthenia Gravis and Myasthenia Gravis Activities of Daily Living scales in the MGTX study.
McPherson T; Aban I; Duda PW; Farzaneh-Far R; Wolfe GI; Kaminski HJ; Cutter G; Lee I;
Muscle Nerve; 2020 Aug; 62(2):261-266. PubMed ID: 32369631
[TBL] [Abstract][Full Text] [Related]
14. Thymus pathology observed in the MGTX trial.
Marx A; Pfister F; Schalke B; Nix W; Ströbel P
Ann N Y Acad Sci; 2012 Dec; 1275():92-100. PubMed ID: 23278583
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and safety of thymectomy plus prednisone compares with prednisone monotherapy for the treatment of non-thymomatous Myasthenia Gravis: Protocol for a systematic review.
Yang H; Liu D; Hong X; Sun H; Zheng Y; Yang B; Wang W
Medicine (Baltimore); 2020 Jun; 99(25):e20832. PubMed ID: 32569233
[TBL] [Abstract][Full Text] [Related]
16. [Indication of thymectomy and immunotherapies on myasthenia gravis].
Murai H
Rinsho Shinkeigaku; 2007 Nov; 47(11):875-6. PubMed ID: 18210823
[TBL] [Abstract][Full Text] [Related]
17. Comparative clinical outcomes of thymectomy for myasthenia gravis performed by extended transsternal and minimally invasive approaches.
Meyer DM; Herbert MA; Sobhani NC; Tavakolian P; Duncan A; Bruns M; Korngut K; Williams J; Prince SL; Huber L; Wolfe GI; Mack MJ
Ann Thorac Surg; 2009 Feb; 87(2):385-90; discussion 390-1. PubMed ID: 19161744
[TBL] [Abstract][Full Text] [Related]
18. A Neurologist's Perspective on Thymectomy for Myasthenia Gravis: Current Perspective and Future Trials.
Mi W; Silvestri NJ; Wolfe GI
Thorac Surg Clin; 2019 May; 29(2):143-150. PubMed ID: 30927995
[TBL] [Abstract][Full Text] [Related]
19. Thymectomy is more effective than conservative treatment for myasthenia gravis regarding outcome and clinical improvement.
Bachmann K; Burkhardt D; Schreiter I; Kaifi J; Schurr P; Busch C; Thayssen G; Izbicki JR; Strate T
Surgery; 2009 Apr; 145(4):392-8. PubMed ID: 19303987
[TBL] [Abstract][Full Text] [Related]
20. Serum metabolomics of treatment response in myasthenia gravis.
Sikorski P; Li Y; Cheema M; Wolfe GI; Kusner LL; Aban I; Kaminski HJ
PLoS One; 2023; 18(10):e0287654. PubMed ID: 37816000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
